There are a number of other malignant tumour types that have been found to harbour NF1 alterations including neuroendocrine prostate cancer (24%), myxofibrosarcomas (10.5%) and pleomorphic liposarcomas (8%), pancreatic cancer (11%), gastric adenocarcinoma (10%) and rhabdomyosarcoma (7%) [44, 45]. Here, NF1 is linked to familial pancreatic carcinoma.